BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kankala RK, Han Y, Xia H, Wang S, Chen A. Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01315-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar P, Salve R, Paknikar KM, Gajbhiye V. Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC. Int J Biol Macromol 2023;229:600-14. [PMID: 36586658 DOI: 10.1016/j.ijbiomac.2022.12.266] [Reference Citation Analysis]
2 Lozano D, Leiva B, Gómez-Escalonilla IS, Portal-Núñez S, de Górtazar AR, Manzano M, Vallet-Regí M. Pleiotrophin-Loaded Mesoporous Silica Nanoparticles as a Possible Treatment for Osteoporosis. Pharmaceutics 2023;15. [PMID: 36839981 DOI: 10.3390/pharmaceutics15020658] [Reference Citation Analysis]
3 Esquivel-castro T, Robledo-trujillo G, Oliva J, Rosu H, Rodríguez-gonzález V. A functional SiO2-TiO2 mesoporous assembly designed for the controlled release of carvacrol. Applied Surface Science Advances 2023;13:100378. [DOI: 10.1016/j.apsadv.2023.100378] [Reference Citation Analysis]
4 Kamil Mohammad Al-Mosawi A, Bahrami AR, Nekooei S, Saljooghi AS, Matin MM. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells. Front Bioeng Biotechnol 2022;10:1095837. [PMID: 36686226 DOI: 10.3389/fbioe.2022.1095837] [Reference Citation Analysis]
5 Lai H, Chen S, Su X, Huang X, Zheng Q, Yang M, Shen B, Yue P. Sponge-liked Silica Nanoporous Particles for Sustaining Release and Long-Term Antibacterial Activity of Natural Essential Oil. Molecules 2023;28. [PMID: 36677650 DOI: 10.3390/molecules28020594] [Reference Citation Analysis]
6 Marinheiro D, Martel F, Ferreira BJML, Daniel-da-Silva AL. Silica-Based Nanomaterials for Diabetes Mellitus Treatment. Bioengineering (Basel) 2022;10. [PMID: 36671612 DOI: 10.3390/bioengineering10010040] [Reference Citation Analysis]
7 Podkolodnaya YA, Kokorina AA, Goryacheva IY. A Facile Approach to the Hydrothermal Synthesis of Silica Nanoparticle/Carbon Nanostructure Luminescent Composites. Materials (Basel) 2022;15. [PMID: 36499966 DOI: 10.3390/ma15238469] [Reference Citation Analysis]
8 Busa P, Kankala RK, Deng JP, Liu CL, Lee CH. Conquering Cancer Multi-Drug Resistance Using Curcumin and Cisplatin Prodrug-Encapsulated Mesoporous Silica Nanoparticles for Synergistic Chemo- and Photodynamic Therapies. Nanomaterials (Basel) 2022;12. [PMID: 36296885 DOI: 10.3390/nano12203693] [Reference Citation Analysis]
9 Gao YM, Chiu SH, Busa P, Liu CL, Kankala RK, Lee CH. Engineered Mesoporous Silica-Based Core-Shell Nanoarchitectures for Synergistic Chemo-Photodynamic Therapies. Int J Mol Sci 2022;23. [PMID: 36232904 DOI: 10.3390/ijms231911604] [Reference Citation Analysis]
10 Nazli A, He DL, Liao D, Khan MZI, Huang C, He Y. Strategies and progresses for enhancing targeted antibiotic delivery. Adv Drug Deliv Rev 2022;189:114502. [PMID: 35998828 DOI: 10.1016/j.addr.2022.114502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li X, Yu Y, Chen Q, Lin J, Zhu X, Liu X, He L, Chen T, He W. Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer. J Nanobiotechnology 2022;20:401. [PMID: 36064356 DOI: 10.1186/s12951-022-01593-5] [Reference Citation Analysis]
12 Wu H, Wang M, Zhu J, Li Z, Wang W, Gu L, Shen F, Yang T. Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics 2022;14:1760. [DOI: 10.3390/pharmaceutics14091760] [Reference Citation Analysis]
13 Ahmadi F, Sodagar-Taleghani A, Ebrahimnejad P, Pouya Hadipour Moghaddam S, Ebrahimnejad F, Asare-Addo K, Nokhodchi A. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer. Int J Pharm 2022;625:122099. [PMID: 35961417 DOI: 10.1016/j.ijpharm.2022.122099] [Reference Citation Analysis]
14 Marques Da Silva V, Benjdir M, Montagne P, Pairon JC, Lanone S, Andujar P. Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review. Nanomaterials (Basel) 2022;12. [PMID: 35889616 DOI: 10.3390/nano12142392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zheng X, Mai X, Bao S, Wang P, Hong Y, Han Y, Sun J, Xiong F. Some Preliminary Results to Eradicate Leukemic Cells in Extracorporeal Circulation by Actuating Doxorubicin-Loaded Nanochains of Fe3O4 Nanoparticles. Cells 2022;11:2007. [DOI: 10.3390/cells11132007] [Reference Citation Analysis]
16 Kumarage S, Munaweera I, Kottegoda N. Contemporary, Multidisciplinary Roles of Mesoporous Silica Nanohybrids/Nanocomposites. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200574] [Reference Citation Analysis]
17 Burdușel A, Gherasim O, Andronescu E, Grumezescu AM, Ficai A. Inorganic Nanoparticles in Bone Healing Applications. Pharmaceutics 2022;14:770. [DOI: 10.3390/pharmaceutics14040770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]